Your browser doesn't support javascript.
loading
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.
Duchmann, Matthieu; Micol, Jean-Baptiste; Duployez, Nicolas; Raffoux, Emmanuel; Thomas, Xavier; Marolleau, Jean-Pierre; Braun, Thorsten; Adès, Lionel; Chantepie, Sylvain; Lemasle, Emilie; Berthon, Céline; Malfuson, Jean-Valère; Pautas, Cécile; Lambert, Juliette; Boissel, Nicolas; Celli-Lebras, Karine; Caillot, Denis; Turlure, Pascal; Vey, Norbert; Pigneux, Arnaud; Recher, Christian; Terré, Christine; Gardin, Claude; Itzykson, Raphaël; Preudhomme, Claude; Dombret, Hervé; de Botton, Stéphane.
Affiliation
  • Duchmann M; Hematology Laboratory, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Micol JB; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique Unité (U)944, INSERM, Centre National de la Recherche Scientifique (CNRS), Paris, France.
  • Duployez N; Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Raffoux E; Laboratory of Hematology, U1277-Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), Centre Hospitalier Universitaire (CHU) Université de Lille INSERM, Lille, France.
  • Thomas X; Research Unit EA-3518, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Marolleau JP; Service Hématologie Adultes, Hôpital Saint-Louis, AP-HP, Paris, France.
  • Braun T; Hematology Department, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre Bénite, France.
  • Adès L; Hematology Department, CHU Amiens, Amiens, France.
  • Chantepie S; Research Unit EA-3518, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Lemasle E; Department of Hematology, Université Paris Nord, Hôpital Avicenne, AP-HP, Bobigny, France.
  • Berthon C; Senior Hematology Unit, Department of Hematology, Hôpital Saint-Louis, AP-HP, Université de Paris, Paris, France.
  • Malfuson JV; Hematology Department, CHU Caen, Caen, France.
  • Pautas C; Hematology Department, Henri Becquerel Center, Rouen, France.
  • Lambert J; Hematology Department, CHU Lille, Lille, France.
  • Boissel N; Hematology Department, Hôpital d'Instruction des Armées (HIA) Percy, Clamart, France.
  • Celli-Lebras K; Hematology Department, Henri Mondor Hospital, AP-HP, Créteil, France.
  • Caillot D; Hematology Department, Versailles Hospital, Le Chesnay, France.
  • Turlure P; Research Unit EA-3518, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Vey N; Adolescent and Young Adult Unit Unit, Department of Hematology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Pigneux A; Acute Leukemia French Association Coordination, Saint-Louis Hospital, Paris, France.
  • Recher C; Hematology Department, CHU Dijon, Dijon, France.
  • Terré C; Hematology Department, Centre Hospitalier Régional Universitaire (CHRU) Limoges, Limoges, France.
  • Gardin C; Hematology Department, Paoli Calmettes Institute, Marseille, France.
  • Itzykson R; Hematology Department, Hôpital Haut-Lévèque, CHU de Bordeaux, Bordeaux, France.
  • Preudhomme C; Institut Universitaire du Cancer de Toulouse Oncopole, CHU de Toulouse, Université de Toulouse 3 Paul Sabatier, Toulouse, France; and.
  • Dombret H; Cytogenetic Laboratory, Versailles Hospital, Le Chesnay, France.
  • de Botton S; Research Unit EA-3518, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
Blood ; 137(20): 2827-2837, 2021 05 20.
Article in En | MEDLINE | ID: mdl-33881523

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Point Mutation / Isocitrate Dehydrogenase / Neoplasm Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Blood Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Point Mutation / Isocitrate Dehydrogenase / Neoplasm Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Blood Year: 2021 Document type: Article Affiliation country: Country of publication: